UAB to participate in global clinical trial for coronavirus treatment
The University of Alabama at Birmingham announced that it will take part in an NIH-sponsored global clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19. The drug remdesivir will be the first agent evaluated in the trial. The UAB site was activated on Wednesday by the National…
UAH lab joins supercomputing effort to find drugs against COVID-19
HUNTSVILLE, Alabama – A researcher at The University of Alabama in Huntsville is joining an effort involving the world’s fastest supercomputer to screen compounds that could be effective against the pandemic COVID-19 virus. Dr. Jerome Baudry, a professor in the Department of Biological Sciences at UAH, said his lab is involved in a project that…
Alabama small businesses can seek SBA COVID-19 disaster loans
MONTGOMERY, Alabama — Governor Kay Ivey announced today that small businesses across Alabama negatively impacted by the coronavirus pandemic are eligible for assistance under the U.S. Small Business Administration’s Economic Injury Disaster Loan (EIDL) program. The SBA program will help qualified businesses and non-profit organizations recover from economic losses tied to the abrupt downturn triggered…
Alabama researchers join global fight against COVID-19 disease
Scientists and researchers in Alabama are engaged in the global effort to stem threats posed by the COVID-19 disease. Today, Huntsville’s Diatherix announced that it has developed a highly sensitive and specific assay, or test, for the SARS-CoV-2 virus that causes the COVID-19 respiratory infection. Diatherix, located on the Huntsville campus of the HudsonAlpha Institute…
